APA

Balbino B., Herviou P., Godon O., Stackowicz J., Goff O. R., Iannascoli B., Sterlin D., Brûlé S., Millot G. A., Harris F. M., Voronina V. A., Nadeau K. C., Macdonald L. E., Murphy A. J., Bruhns P. & Reber L. L. (20201103). The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. : The Journal of clinical investigation.

Chicago

Balbino Bianca, Herviou Pauline, Godon Ophélie, Stackowicz Julien, Goff Odile Richard-Le, Iannascoli Bruno, Sterlin Delphine, Brûlé Sébastien, Millot Gael A, Harris Faith M, Voronina Vera A, Nadeau Kari C, Macdonald Lynn E, Murphy Andrew J, Bruhns Pierre and Reber Laurent L. 20201103. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. : The Journal of clinical investigation.

Harvard

Balbino B., Herviou P., Godon O., Stackowicz J., Goff O. R., Iannascoli B., Sterlin D., Brûlé S., Millot G. A., Harris F. M., Voronina V. A., Nadeau K. C., Macdonald L. E., Murphy A. J., Bruhns P. and Reber L. L. (20201103). The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. : The Journal of clinical investigation.

MLA

Balbino Bianca, Herviou Pauline, Godon Ophélie, Stackowicz Julien, Goff Odile Richard-Le, Iannascoli Bruno, Sterlin Delphine, Brûlé Sébastien, Millot Gael A, Harris Faith M, Voronina Vera A, Nadeau Kari C, Macdonald Lynn E, Murphy Andrew J, Bruhns Pierre and Reber Laurent L. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. : The Journal of clinical investigation. 20201103.